🔎 Trials Near Me

Akèy › Myelom Miltip › Florid › Jacksonville

Etid klinik pou Myelom Miltip nan Jacksonville, FL

18 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Jacksonville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Ap rekrite
  • Mayo Clinic in Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06630104

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 3
  • Mayo Clinic Jacksonville, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 3
  • Mayo Clinic Jacksonville, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07258511

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Mayo Clinic in Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06465316

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Ap rekriteFaz 3
  • Baptist MD Anderson Cancer Center, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 2
  • Mayo Clinic in Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06297226

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Mayo Clinic Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06375044

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Mayo Clinic Hospital - Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Ap rekriteFaz 1/2
  • Research Site, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05850234

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Ap rekriteFaz 2
  • Mayo Clinic - Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07284758

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

Ap rekriteFaz 2
  • Mayo Clinic in Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05847569

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Ap rekriteFaz 3
  • Mayo Clinic in Florida, Jacksonville
Tout laj · Tout sèks · Mizajou Jun 10, 2026 · NCT05561387

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Ap rekriteFaz 2
  • Mayo Clinic in Florida, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT05969860

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Ap rekriteFaz 1
  • Cancer Specialists, LLC, Jacksonville
Laj 18 ak plis · Tout sèks · Mizajou Nov 1, 2023 · NCT03110822

Etid Myelom Miltip nan lòt vil

Lòt etid nan Jacksonville

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.